Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
Delayed Quote. Delayed Nasdaq - 09/21 04:00:00 pm
341.35 USD   +0.69%
06:23aEUROPEAN MIDDAY BRIEFING : Stocks Rebound But -3-
DJ
06:23aEUROPEAN MIDDAY BRIEFING : Stocks Rebound But -2-
DJ
06:04aNORTH AMERICAN MORNING BRIEFING : Markets Steady -2-
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

European ADRs Move Higher in Monday Trading

07/26/2021 | 11:14am EDT


© MT Newswires 2021
All news about BIONTECH SE
06:23aEUROPEAN MIDDAY BRIEFING : Stocks Rebound But -3-
DJ
06:23aEUROPEAN MIDDAY BRIEFING : Stocks Rebound But -2-
DJ
06:04aNORTH AMERICAN MORNING BRIEFING : Markets Steady -2-
DJ
09/20PFIZER : vaccine found to be safe, effective for children aged 5-11
AQ
09/20PFIZER : announces its vaccine is effective for kids 5-11
AQ
09/20Healthcare Shares Fall Amid Concerns About Delta Variant -- Healthcare Roundup
DJ
09/20PFIZER : BioNTech Study Shows COVID-19 Vaccine Generates Strong Immune Response in Childre..
MT
09/20MODERNA : Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in kids
RE
09/20Health Care Stocks Trade Lower Pre-Bell Monday
MT
09/20PFIZER : BioNTech Say COVID-19 Vaccine Show 'Strong Immune Response' in Children Aged 5 to..
MT
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Financials
Sales 2021 16 863 M 19 759 M 19 759 M
Net income 2021 8 881 M 10 406 M 10 406 M
Net cash 2021 9 100 M 10 663 M 10 663 M
P/E ratio 2021 8,21x
Yield 2021 -
Capitalization 70 338 M 82 443 M 82 419 M
EV / Sales 2021 3,63x
EV / Sales 2022 2,89x
Nbr of Employees 2 500
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Last Close Price 291,23 €
Average target price 279,54 €
Spread / Average Target -4,01%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE318.73%81 878
GILEAD SCIENCES, INC.21.80%88 970
WUXI APPTEC CO., LTD.35.75%69 413
REGENERON PHARMACEUTICALS32.66%66 632
VERTEX PHARMACEUTICALS-21.44%48 168
BEIGENE, LTD.54.22%37 076